Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VAISHALI PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 VAISHALI PHARMA    ACTAVIS
EQUITY SHARE DATA
    VAISHALI PHARMA
Mar-23
ACTAVIS
Dec-18
VAISHALI PHARMA /
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs19416,126-   
Low Rs6410,818-   
Sales per share (Unadj.) Rs66.03,955.8-  
Earnings per share (Unadj.) Rs6.3-1,274.2-  
Cash flow per share (Unadj.) Rs6.7416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs31.316,315.7-  
Shares outstanding (eoy) m10.55332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.03.4 57.4%   
Avg P/E ratio x20.6-10.6 -194.9%  
P/CF ratio (eoy) x19.132.3 59.2%  
Price / Book Value ratio x4.10.8 499.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,3614,480,758 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m130-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m6971,315,689 0.1%  
Other income Rs m2225,160 0.1%   
Total revenues Rs m7191,340,849 0.1%   
Gross profit Rs m9434,478 0.3%  
Depreciation Rs m5562,428 0.0%   
Interest Rs m2375,923 0.0%   
Profit before tax Rs m88-578,713 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m22-7,334 -0.3%   
Profit after tax Rs m66-423,784 -0.0%  
Gross profit margin %13.52.6 513.7%  
Effective tax rate %25.41.3 2,000.6%   
Net profit margin %9.5-32.2 -29.4%  
BALANCE SHEET DATA
Current assets Rs m727539,627 0.1%   
Current liabilities Rs m321477,372 0.1%   
Net working cap to sales %58.34.7 1,231.8%  
Current ratio x2.31.1 200.5%  
Inventory Days Days1820 91.8%  
Debtors Days Days2,80966 4,236.1%  
Net fixed assets Rs m61148,929 0.0%   
Share capital Rs m1050-   
"Free" reserves Rs m2240-   
Net worth Rs m3305,426,601 0.0%   
Long term debt Rs m521,910,903 0.0%   
Total assets Rs m7888,483,012 0.0%  
Interest coverage x4.9-6.6 -74.3%   
Debt to equity ratio x0.20.4 45.0%  
Sales to assets ratio x0.90.2 570.3%   
Return on assets %11.2-4.1 -274.3%  
Return on equity %20.0-7.8 -256.5%  
Return on capital %29.1-4.8 -600.4%  
Exports to sales %25.20-   
Imports to sales %7.80-   
Net fx Rs m1210-   
CASH FLOW
From Operations Rs m11470,046 0.0%  
From Investments Rs m3258,229 0.0%  
From Financial Activity Rs m-17-806,740 0.0%  
Net Cashflow Rs m-4-78,073 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare VAISHALI PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare VAISHALI PHARMA With: HINDUSTAN BIOSCIE  CHANDRA BHAGAT PHARMA  ADVANCED ENZYME TECHNOLOGIES  EARUM PHARMACEUTICALS  KOPRAN.  



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.